Agile Therapeutics | AGRX - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Agile Therapeutics

Agile Therapeutics reported $4.01M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Adma Biologics ADMA:US USD 40.5M 4.7M
Agile Therapeutics AGRX:US USD 4.01M 2.35M
Bayer BAYN:GR EUR 5.73B 965M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
J&J JNJ:US USD 8.4B 684M
Merck & Co MRK:US USD 3.35B 491M
Pacira PCRX:US USD 49.02M 12.9M
Pfizer PFE:US USD 5.03B 4.8B